Search - tctmd.com

Displaying 41 - 60 of 117

Sort: Relevancy | Date

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

Presentation TCT Abstracts Posters 2019

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Presenter: Cecillia Y Wong

October 28, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Advertisement

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

High Mortality but Durable Results With Valve-in-Valve TAVR

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content